English  |  正體中文  |  简体中文  |  2816861  
???header.visitor??? :  27603579    ???header.onlineuser??? :  503
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"kuo k l"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 101-125 of 147  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-12-04T07:45:02Z Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F.
臺大學術典藏 2020-12-01T07:10:11Z Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F.; Hu F.-C.; Chang H.-W.; Lin L.-Y.; YI-LWUN HO; Wu K.-D.; Wu V.-C.; Hung S.-C.; Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.
臺大學術典藏 2020-09-30T01:17:16Z Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease Wu V.-C.; Hsieh T.-C.; for the National Taiwan University Study Group on Acute Renal Failure (NSARF); Wu K.-D.; Wu C.-H.; YA-WEN YANG; Hung S.-C.; Kuo K.-L.
臺大學術典藏 2020-09-28T07:04:51Z Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism Liu K.-L.; Lin L.-Y.; Hu F.-C.; Chang H.-W.; Ho Y.-L.; Wu K.-D.; Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Liao S.-C.; Yen R.-F.; Lu C.-C.; Chueh S.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.
臺大學術典藏 2020-09-28T07:04:33Z Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease for the National Taiwan University Study Group on Acute Renal Failure (NSARF); Wu C.-H.; Yang Y.-W.; Hung S.-C.; Kuo K.-L.; Wu K.-D.; Hsieh T.-C.
臺大學術典藏 2020-06-30T08:51:19Z Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients Kuo K.-L.;Hung S.-C.;Lin Y.-P.;Tang C.-F.;Tzong-Shyuan Lee;Lin C.-P.;Tarng D.-C.; Kuo K.-L.; Hung S.-C.; Lin Y.-P.; Tang C.-F.; TZONG-SHYUAN LEE; Lin C.-P.; Tarng D.-C.
臺大學術典藏 2020-06-30T08:51:15Z Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD Kuo K.-L.;Hung S.-C.;Tzong-Shyuan Lee;Tarng D.-C.; Kuo K.-L.; Hung S.-C.; TZONG-SHYUAN LEE; Tarng D.-C.
臺大學術典藏 2020-06-30T08:51:13Z Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy Chiang C.-W.;Lee H.-T.;Tarng D.-C.;Kuo K.-L.;Cheng L.-C.;Tzong-Shyuan Lee; Chiang C.-W.; Lee H.-T.; Tarng D.-C.; Kuo K.-L.; Cheng L.-C.; TZONG-SHYUAN LEE
臺大學術典藏 2020-06-30T08:51:06Z Indoxyl sulfate impairs valsartan-induced neovascularization Kuo K.-L.;Zhao J.-F.;Huang P.-H.;Guo B.-C.;Tarng D.-C.;Tzong-Shyuan Lee; Kuo K.-L.; Zhao J.-F.; Huang P.-H.; Guo B.-C.; Tarng D.-C.; TZONG-SHYUAN LEE
臺大學術典藏 2020-06-26T03:31:42Z Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism Wu C.-H.;Yang Y.-W.;Hu Y.-H.;Tsai Y.-C.;Kuo K.-L.;Lin Y.-H.;Hung S.-C.;Wu V.-C.;Wu K.-D.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Huang K.-H.;Chen Y.-M.;Kuo C.-C.;Chang C.-C.;Chueh S.-C.;Lu C.-C.;Shih-Cheng Liao;Yen R.-F.; Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Shih-Cheng Liao; Yen R.-F.
臺大學術典藏 2020-03-06T08:25:03Z MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; YUNG-MING JENG; Huang K.-H.; Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Liu S.-H.;Yung-Ming Jeng;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.
臺大學術典藏 2020-01-23T01:37:24Z Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H.
臺大學術典藏 2020-01-23T01:37:23Z Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) Huang K.-H.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y.
臺大學術典藏 2020-01-23T01:37:23Z Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Po-Ming Chow;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H.
臺大學術典藏 2020-01-23T01:37:21Z The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma Po-Ming Chow;Liu S.-H.;Chang Y.-W.;Kuo K.-L.;Lin W.-C.;Huang K.-H.; PO-MING CHOW; Liu S.-H.; Chang Y.-W.; Kuo K.-L.; Lin W.-C.; Huang K.-H.
臺大學術典藏 2019-12-04T08:43:33Z Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians Chen C.-B.;Hsiao Y.-H.;Wu T.;Hsih M.-S.;Tassaneeyakul W.;Jorns T.P.;Sukasem C.;Hsu C.-N.;Su S.-C.;Chang W.-C.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Sun P.-L.;Lee H.-E.;Yang C.-Y.;Kao P.-H.;Yang C.-H.;Ho H.-C.;Lin J.-Y.;Chang Y.-C.;Chen M.-J.;Lu C.-W.;Ng C.Y.;Kuo K.-L.;Lin C.-Y.;Yang C.-S.;Chen D.-P.;Chang P.-Y.;Wu T.-L.;Lin Y.-J.;Weng Y.-C.;Kuo T.-T.;Hung S.-I.;Chung W.-H.;For The Taiwan Severe Cutaneous Adverse Reaction Consortium; Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium
臺大學術典藏 2019-11-12T07:36:33Z MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Shing-Hwa Liu;Jeng Y.-M.;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; SHING-HWA LIU; Jeng Y.-M.; Huang K.-H.
臺大學術典藏 2019-11-12T07:36:27Z Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity Chao S.-C.;Chen Y.-J.;Huang K.-H.;Kuo K.-L.;Yang T.-H.;Huang K.-Y.;Wang C.-C.;Tang C.-H.;Yang R.-S.;Shing-Hwa Liu; Chao S.-C.; Chen Y.-J.; Huang K.-H.; Kuo K.-L.; Yang T.-H.; Huang K.-Y.; Wang C.-C.; Tang C.-H.; Yang R.-S.; SHING-HWA LIU
臺大學術典藏 2019-11-12T07:36:21Z Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H.; Lin W.-C.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Shing-Hwa Liu;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.
臺大學術典藏 2019-11-12T07:36:17Z Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Shing-Hwa Liu;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H.
臺大學術典藏 2019-11-12T07:36:15Z Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study Huang K.-H.; Kuo K.-L.;Shing-Hwa Liu;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Huang K.-H.; Kuo K.-L.; SHING-HWA LIU; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.
臺大學術典藏 2019 Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Po-Ming Chow;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; PO-MING CHOW; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H.
臺大學術典藏 2018-09-10T15:28:01Z MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study Lin, W.-C.;Kuo, K.-L.;Shi, C.-S.;Wu, J.-T.;Hsieh, J.-T.;Chang, H.-C.;Liao, S.-M.;Chou, C.-T.;Chiang, C.-K.;Chiu, W.-S.;Chiu, T.-Y.;Pu, Y.-S.;Ho, I.-L.;Wang, Z.-H.;Chang, S.-C.;Liu, S.-H.;Jeng, Y.-M.;Huang, K.-H.; WEI-CHOU LIN
臺大學術典藏 2018-09-10T15:17:28Z Knowledge of the new tobacco hazards prevention act is associated with smokers' behavior of seeking help in smoking cessation in Taiwan Wu, T.-Y. ; Chie, W.-C. ; Lai, M.-S. ; Chen, C.-C. ; Kuo, K.-L. ; Majeed, A.; WEI-CHU CHIE
臺大學術典藏 2018-09-10T09:52:52Z Factors associated with falls among community-dwelling older people in Taiwan Wu, T.Y.;Chie, W.C.;Yang, R.S.;Liu, J.P.;Kuo, K.L.;Wong, W.K.;Liaw, C.K.; RONG-SEN YANG

Showing items 101-125 of 147  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page